Skip to content
TheChatArchiveThe Chat Archive
o1-mini-2024-09-12· OpenAIAi2 WildChat-4.8M (AI2)

translate the following into Chinese: Final Refined Summary: The article explores…

  1. User

    translate the following into Chinese: Final Refined Summary:

    The article explores infective endocarditis (IE) caused by rare and fastidious bacteria, which frequently lead to culture-negative cases and complicate the diagnostic process. While IE is typically diagnosed through persistent bacteremia with gram-positive cocci and the detection of vegetations via echocardiography, advanced echocardiographic techniques—particularly transesophageal echocardiography—significantly enhance the sensitivity of the Duke criteria. However, echocardiography is more effective in confirming the presence of IE rather than identifying the specific microbial cause, with approximately 24% of proven IE cases being misclassified as “possible” when blood cultures are negative. In older patients, the most prevalent underlying heart disease factor is prosthetic valve replacement, observed in one-third of such cases. Additionally, poor dental hygiene or recent oral surgery has been associated with an increased risk of infection.

    Uncommon Pathogens and Specialized Diagnostics:

    Uncommon pathogens such as Bartonella spp., Coxiella burnetii, Lactobacillus, Legionella spp., Chlamydia psittaci, members of the HACEK group, Klebsiella spp., Serratia marcescens, Neisseria spp., Listeria monocytogenes, Nocardia spp., Erysipelothrix rhusiopathiae, Clostridium spp., Corynebacterium diphtheriae, Abiotrophia spp., and Gemella spp. necessitate specialized diagnostic approaches.

    For instance:

    • Bartonella spp., including B. henselae and B. quintana, require serological tests, PCR amplification of specific genes (such as the 16S rRNA gene), special staining techniques like Warthin-Starry, and optimized culture conditions.

    • Whipple's Disease caused by Tropheryma whippelii is diagnosed through the presence of PAS-positive macrophages in biopsy specimens and confirmed by PCR and sequencing.

    • Legionella spp. endocarditis necessitates buffered charcoal yeast extract (BCYE) media and PCR for accurate identification.

    • Chlamydia psittaci endocarditis often requires advanced molecular techniques due to serological cross-reactivity with Bartonella spp.

    • Coxiella burnetii (Q fever) diagnosis involves high-phase I IgG and IgA antibodies, PCR, and histologic observation of infected tissues.

    • HACEK Group Bacteria require prolonged incubation times and specific culture conditions, including subculture on 5 to 8% sheep blood and chocolate agar in a CO₂-enriched environment.

    • Klebsiella spp., particularly K. pneumoniae and K. oxytoca, are associated with high virulence, often originating from urinary tract infections, and require continuous bacteremia detection through positive blood cultures.

    • Serratia marcescens endocarditis is predominantly seen in intravenous drug users, with a high mortality rate if diagnosis is delayed.

    • Neisseria spp., including N. gonorrhoeae and other species like N. elongata and N. sicca, present with acute febrile endocarditis and often require valve replacement alongside antibiotic therapy.

    • Listeria monocytogenes endocarditis occurs mostly in immunocompromised individuals and is treated with ampicillin and aminoglycosides.

    • Nocardia spp. endocarditis, though exceedingly rare, is associated with prosthetic valves and requires aggressive antibiotic therapy combined with surgical intervention.

    • Erysipelothrix rhusiopathiae endocarditis is linked to occupational exposure and animal contact, diagnosed via positive blood cultures, and treated with penicillin G.

    • Clostridium spp. endocarditis presents with clostridial sepsis symptoms and requires prompt antibiotic therapy, though prognosis remains poor.

    • Corynebacterium diphtheriae endocarditis, often linked to respiratory or skin sources, is treated with penicillin and aminoglycosides.

    • Abiotrophia spp. (formerly nutritionally variant streptococci) and Gemella spp. require molecular identification techniques and are treated with high-dose penicillin and aminoglycosides.

      • Abiotrophia spp. cause approximately 5 to 6% of all streptococcal endocarditis cases. These fastidious organisms are often misdiagnosed as culture-negative IE, potentially underestimating their prevalence. Preexisting heart disease is found in 90% of patients, with prosthetic heart valves involved in only 10% of cases. Clinical presentations are typically slow and indolent, with complications such as septic arthritis observed as the disease progresses. Diagnosis has improved with enhanced culture media, including cysteine supplementation, and molecular techniques like 16S rRNA gene sequencing. Treatment is challenging due to high rates of bacteriological failure (41%) despite antibiotic therapy, necessitating combination treatments such as penicillin with gentamicin or vancomycin alone in certain cases. Morbidity and mortality exceed those of other streptococcal forms, with significant proportions of patients requiring valve replacement or succumbing to uncontrolled heart failure or embolic events.

      • Gemella spp., including Gemella morbillorum and Gemella haemolysans, are easily decolorized during Gram staining and often misidentified as gram-negative cocci. They account for a notable percentage of misclassified viridans group streptococci. Endocarditis due to Gemella spp. is associated with poor dental hygiene and previous valvular damage, presenting with low-grade intermittent fever and new or modified cardiac murmurs in two-thirds of cases. Embolic manifestations are common, and diagnosis relies on accurate Gram staining interpretation and molecular identification methods like 16S rRNA gene sequencing. Treatment typically involves penicillin and gentamicin, with reported outcomes being favorable, including low fatality rates and minimal requirement for surgical interventions.

    HACEK Group Bacteria:

    The HACEK group comprises fastidious, small gram-negative bacilli primarily from the oropharyngeal flora, responsible for approximately 3% of all endocarditis cases. This group includes Haemophilus parainfluenzae, H. influenzae, H. aphrophilus, H. paraphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella spp. These organisms are slow-growing, with growth enhanced by carbon dioxide, and require specific culture conditions. Each HACEK organism demonstrates unique epidemiological and clinical characteristics:

    • Haemophilus paraphrophilus: Rare, often associated with mitral valve prolapse and previous valve abnormalities. Clinical features include fever, cardiac murmurs, and embolic events. Valve replacement is required in 24% of cases.

    • Haemophilus aphrophilus: Commonly linked to dental procedures and upper respiratory infections. Echocardiography detects vegetations in 70% of patients. Improved diagnostic delay has led to better prognoses in recent reports.

    • Haemophilus parainfluenzae: Presents insidiously, often following dental procedures. Embolic complications are frequent, with a case fatality rate between 10-35%.

    • Actinobacillus actinomycetemcomitans: Associated with periodontal disease and prior dental infections. Affects young to middle-aged patients, with a case fatality rate of 9-15% and valve replacement required in 28% of cases.

    • Cardiobacterium hominis: Linked to dental infections and underlying heart disease, predominantly affecting the aortic valve. Mortality is around 13%, with 30% requiring valve replacement.

    • Eikenella corrodens: Often found in intravenous drug users due to syringe contamination. Generally causes a mild course with a 15% fatality rate and rare need for valve replacement.

    • Kingella spp.: Kingella kingae primarily affects young children, while Kingella denitrificans is less common. In older patients, prosthetic valves are a significant risk factor. Kingella spp. predominantly colonize the upper respiratory tract, particularly the tonsils, and are not primary pathogens but exploit mucosal impairments resulting from viral infections. Concomitant stomatitis, pharyngitis, or varicella virus-induced buccal ulcers have been reported in children with Kingella bacteremia. A fatality rate of 16% has been reported in K. kingae endocarditis, with central nervous system emboli detected in 25% of cases.

    Effective Identification Strategies:

    Effective identification strategies include obtaining multiple blood cultures under stringent conditions—typically three sets within 24 to 48 hours with adequate blood volume—to establish culture-positive endocarditis. Due to the slow growth of HACEK bacteria and other fastidious organisms, prolonged incubation times (3 to 5 days, potentially up to 30 days for organisms like A. actinomycetemcomitans) are essential. Specialized culture methods, such as subculture on 5 to 8% sheep blood and chocolate agar at 35 to 37°C in 5 to 10% CO₂, are required. Molecular techniques using 16S rRNA gene analysis may be necessary for difficult identifications. Prior antibiotic therapy, common in many patients, can significantly reduce blood culture yields. To mitigate this, methods such as diluting blood samples in broth, using antimicrobial agent removal devices, and employing specialized culture media are essential for isolating fastidious organisms. No significant difference in bacterial growth was found between the Septicheck bottle and the Isolator tube.

    Clinical Presentations and Diagnostic Challenges:

    IE caused by these atypical organisms may present with subacute and insidious symptoms, often lacking conventional signs like fever and cardiac murmurs, especially in elderly patients or those who have received prior antibiotics. Additional clinical manifestations include:

    • Digital Clubbing: Observed in one-third of patients, a higher rate than typically seen in other forms of endocarditis.

    • Purpuric Rash: Found in one-fifth of patients, usually occurring on the extremities and mucosa. Skin biopsies reveal immune complex vasculitis.

    • Renal Involvement: Proliferative glomerulonephritis has been reported, increasing the risk of renal insufficiency. Laboratory findings may include microscopic hematuria, elevated serum hepatic transaminases, lactate dehydrogenase, creatine phosphokinase, cryoglobulins, and hyperglobulinemia.

    • Embolic Manifestations: Occur in about 20-41% of patients, involving cerebral and extremity vessels. Arterial embolism may present as stroke, potentially requiring embolectomy or amputation.

    • Pulmonary and Pleural Manifestations: Can be complications of endocarditis.

    Specific Presentations in Rare IE Types:

    • Whipple's Disease Endocarditis: May include systemic symptoms like diarrhea, weight loss, neurological manifestations, and acute congestive heart failure.

    • Legionella Endocarditis: Associated with chronic symptoms such as low-grade fever, night sweats, weight loss, and signs of congestive heart failure without embolic events.

    • Coxiella burnetii Endocarditis (Q Fever): Typically affects individuals with preexisting valvular injuries, presenting with prolonged fever, cardiac dysfunction, splenomegaly, and hepatomegaly. Laboratory findings often include high-phase IgG and IgA antibodies, circulating immune complexes, rheumatoid factor, anemia, thrombocytopenia, hyperglobulinemia, and various autoantibodies.

    • Klebsiella Endocarditis: Characterized by antecedent urinary tract infections, high virulence with native and prosthetic valve involvement, continuous bacteremia, and a high mortality rate (49%) if diagnosis is delayed. Echocardiography usually demonstrates large vegetations, and blood cultures are always positive. Cardiac murmurs may be absent or missed, especially in right-sided endocarditis. Myocardial abscesses may lead to culture-negative diagnoses, eventually identified post-surgery.

    • Neisseria gonorrhoeae Endocarditis: Presents in younger patients (mean age 27) with a prolonged symptom duration (~45 days), fever in 60%, and acute congestive heart failure in one-third. Associated with sexually transmitted diseases and often requires valve replacement (50% of cases) with a high mortality rate (25%) despite antibiotic therapy.

    • Listeria monocytogenes Endocarditis: Occurs mainly in immunocompromised individuals, presenting as a subacute disease with fever, weakness, dyspnea, and cardiac murmurs. Acute congestive heart failure is common (50%), and treatment involves ampicillin and aminoglycosides.

    • Lactobacillus Endocarditis: Associated with dental manipulations in 75% of cases and a high frequency of systemic emboli (42%). Underlying heart disease is present in 83% of patients, and relapse occurs in 39% of inadequately treated cases.

    • Nocardia spp. Endocarditis: Extremely rare, mostly in patients with prosthetic valves, with a high mortality rate (67%) despite treatment involving intravenous antibiotics and valve replacement.

    • Erysipelothrix rhusiopathiae Endocarditis: Linked to occupational exposure (89%), particularly in butchers and fishermen, with characteristic skin lesions (erysipeloid) in 40% of patients. Treatment with penicillin G is effective, though mortality remains high (38%).

    • Clostridium spp. Endocarditis: Presents with clostridial sepsis symptoms such as shock, jaundice, and intravascular hemolysis. Associated with high mortality (47%) despite antibiotic treatment, often linked to intravenous drug use or underlying malignancies.

    • Corynebacterium diphtheriae Endocarditis: Often occurs in the context of pharyngitis or intravenous drug use, with underlying heart diseases like valve damage. Treated with penicillin and aminoglycosides.

    • Abiotrophia spp. Endocarditis: Characterized by a slow and indolent course, often in patients with preexisting heart disease (90%). Classical peripheral manifestations like digital clubbing, petechiae, and Osler nodes are infrequent, but embolization occurs in one-third of patients. Diagnosis has improved with specialized culture media and molecular techniques. Treatment is challenging due to high rates of bacteriological failure and resistance to penicillin in over 30% of strains. Combination therapies, such as penicillin with gentamicin or vancomycin alone, have shown effectiveness in certain models and patient populations. Prognosis remains poor with significant mortality and a high need for valve replacement.

    • Gemella spp. Endocarditis: Associated with poor dental hygiene and previous valvular damage, presenting with low-grade intermittent fever and new or modified cardiac murmurs in two-thirds of cases. Embolic events are common, and diagnosis relies on accurate Gram stain interpretation and molecular identification. Treatment typically involves penicillin and gentamicin, with favorable outcomes reported, including low fatality rates and minimal surgical interventions.

    Treatment and Prognosis:

    Treatment of IE caused by rare pathogens typically involves a combination of antibiotics tailored to the specific organism's susceptibility profile:

    • Bartonella Endocarditis: Often treated with aminoglycosides in combination with doxycycline or ceftriaxone for a prolonged course.

    • Whipple's Disease Endocarditis: Requires prolonged antibiotic therapy targeting T. whippelii, often necessitating surgical intervention such as valve replacement due to extensive valvular damage.

    • Legionella Endocarditis: Treated with macrolides or fluoroquinolones.

    • Coxiella burnetii Endocarditis (Q Fever): Typically requires doxycycline combined with hydroxychloroquine for at least 18 months, along with serum antibody surveillance and plasma level monitoring of hydroxychloroquine.

    • HACEK Group Bacteria: Treated with β-lactamase-stable cephalosporins for 4 weeks (native valves) or 6 weeks (prosthetic valves). Prophylaxis for dental procedures includes amoxicillin, with alternatives like clindamycin or pristinamycin for allergic patients.

    • Klebsiella Endocarditis: Managed with broad-spectrum cephalosporins or fluoroquinolones, though high mortality necessitates prompt diagnosis and aggressive treatment.

    • Neisseria Endocarditis: Requires appropriate antibiotic therapy and often valve replacement, with improved outcomes in recent years.

    • Listeria and Lactobacillus Endocarditis: Treated with combinations such as ampicillin and aminoglycosides, with considerations for high relapse and mortality rates in inadequately treated cases.

    • Nocardia, Erysipelothrix, Clostridium, Corynebacterium, Abiotrophia, and Gemella Endocarditis: Require specific antibiotic regimens, often combined with surgical interventions, to improve prognosis. Mortality rates vary, with some infections like Clostridium spp. having particularly poor outcomes despite treatment.

    • Gemella spp. specifically respond well to penicillin and gentamicin, with reported favorable outcomes and low fatality rates.

    The prognosis of IE caused by rare pathogens can be poor, especially in cases with delayed diagnosis and treatment. High mortality rates are noted in infections like Klebsiella and Clostridium endocarditis. However, advancements in diagnostic and therapeutic strategies, including the use of molecular techniques and tailored antibiotic therapies, have improved outcomes for many patients. Early identification and appropriate management are crucial for reducing mortality and the need for surgical interventions.

    Other Rare Etiologies:

    Beyond the detailed pathogens, other rare causative agents of IE include:

    • Mycobacterium spp.: Acid-alcohol-resistant bacteria causing exceptionally rare forms of endocarditis, often associated with prosthetic valves or medical procedures. Diagnosis relies on histologic examination and specialized culture techniques, with combination antibiotic therapy recommended.

    • Mycoplasma spp.: Cell wall-deficient bacteria implicated in very few reported cases of IE. Detection is challenging due to their inability to be visualized by Gram stain and growth in routine cultures. Strategies for isolation include specific agar media and PCR techniques.

    • Pasteurella spp.: Small, gram-negative, nonmotile coccobacilli commonly associated with close contact with cats or dogs (44% of cases). Endocarditis caused by Pasteurella spp. has been reported in 21 cases, with a mortality rate of 31%, often related to diagnostic delays rather than antibiotic resistance.

    • Brucella spp.: Small, facultative, gram-negative, intracellular bacteria causing zoonotic infections primarily through ingestion of contaminated milk or close contact with infected animals. Brucella endocarditis occurs in 0.3-0.6% of brucellosis cases, with a high fatality rate. Diagnosis relies on prolonged blood culture incubation and serological tests, while treatment typically involves a combination of doxycycline and rifampin or streptomycin for several months, often accompanied by surgical intervention.

    • Bordetella spp.: Only one reported case of Bordetella holmesii endocarditis, diagnosed via molecular techniques after isolation from blood culture in a patient with a bicuspid aortic valve.

    • Francisella tularensis: A single reported case of endocarditis, identified through extended blood culture incubation using radiometric systems.

    • Aeromonas hydrophila: Two reported cases of endocarditis in cirrhotic patients, associated with waterborne exposure.

    • Yersinia enterocolitica: Twelve reported cases of endocarditis, often in patients with underlying conditions such as iron-overloading states or immunosuppression. Treatment typically involves broad-spectrum cephalosporins and gentamicin, with a 25% mortality rate in untreated cases.

    • Salmonella spp.: Thirty-three reported cases of endocarditis, primarily Salmonella enterica serovar Enteritidis. Occurs mostly during or after concomitant Salmonella infections like gastroenteritis, especially in immunocompromised individuals or those with prosthetic valves. Echocardiography usually demonstrates large vegetations with positive blood cultures.

    Conclusion:

    The integration of enhanced echocardiographic methods with the Duke criteria, combined with advanced microbiological and molecular diagnostics, significantly improves the detection and management of infective endocarditis caused by less common and fastidious bacterial agents. Understanding the epidemiology, clinical presentations, and appropriate diagnostic and therapeutic strategies for these rare pathogens is essential for improving patient outcomes. Active investigation for atypical organisms, especially in culture-negative cases, and a high index of suspicion based on patient history and clinical features are crucial for timely and accurate diagnosis and effective treatment.

    Acknowledgment

    We thank J. S. Dumler (Johns Hopkins Medical Institution, Baltimore, Md.) for a review of English usage.

  2. Assistant

    最终精炼摘要:

    本文探讨了由罕见且难培养的细菌引起的感染性心内膜炎(IE),这些细菌常导致培养阴性病例并使诊断过程复杂化。虽然IE通常通过持续的葡萄球菌血症和通过超声心动图检测到的植被进行诊断,但先进的超声心动图技术——特别是经食道超声心动图——显著提高了Duke标准的敏感性。然而,超声心动图在确认IE的存在方面更为有效,而在识别具体微生物原因方面效果较差,当血培养为阴性时,大约24%的确诊IE病例被误分类为“可能”。在老年患者中,最常见的潜在心脏病因素是假体瓣膜置换术,这在此类病例中占三分之一。此外,口腔卫生差或近期口腔手术与感染风险增加有关。

    少见病原体和专门诊断:

    少见的病原体,如巴通体属 (Bartonella spp.)、Q热立克次体 (Coxiella burnetii)、乳酸杆菌 (Lactobacillus)、军团菌属 (Legionella spp.)、鸟型衣原体 (Chlamydia psittaci)、HACEK 组细菌、克雷伯菌属 (Klebsiella spp.)、窦氏变形杆菌 (Serratia marcescens)、奈瑟菌属 (Neisseria spp.)、李斯特菌 (Listeria monocytogenes)、诺卡氏菌属 (Nocardia spp.)、红脓丝状杆菌 (Erysipelothrix rhusiopathiae)、产气荚膜梭菌属 (Clostridium spp.)、白喉棒状杆菌 (Corynebacterium diphtheriae)、不需营养链球菌属 (Abiotrophia spp.) 和 珍珠链球菌属 (Gemella spp.) 需要专门的诊断方法。

    例如:

    • 巴通体属 (Bartonella spp.),包括 B. henselae 和 B. quintana,需要血清学检测、特定基因(如16S rRNA基因)的PCR扩增、特殊染色技术如Warthin-Starry染色,以及优化的培养条件。

    • 惠普尔病 (Whipple's Disease) 由 Tropheryma whippelii 引起,通过活检标本中PAS阳性的巨噬细胞进行诊断,并通过PCR和测序确认。

    • 军团菌属 (Legionella spp.) 心内膜炎需要缓冲木炭酵母提取物(BCYE)培养基和PCR以准确鉴定。

    • 鸟型衣原体 (Chlamydia psittaci) 心内膜炎通常需要先进的分子技术,因为其血清学与巴通体属存在交叉反应。

    • Q热立克次体 (Coxiella burnetii)(Q热)诊断涉及高阶段I的IgG和IgA抗体、PCR及感染组织的组织学观察。

    • HACEK组细菌 需要延长培养时间和特定的培养条件,包括在5-8%羊血培养基和增二氧化碳的巧克力琼脂培养基上进行亚培养。

    • 克雷伯菌属 (Klebsiella spp.),特别是K. pneumoniae和K. oxytoca,具有高毒力,常源自尿路感染,并需要通过阳性血培养持续检测菌血症。

    • 窦氏变形杆菌 (Serratia marcescens) 心内膜炎主要见于静脉吸毒者,如诊断延误,死亡率高。

    • 奈瑟菌属 (Neisseria spp.),包括N. gonorrhoeae及其他种类如N. elongata和N. sicca,表现为急性发热性心内膜炎,通常需进行瓣膜置换及抗生素治疗。

    • 李斯特菌 (Listeria monocytogenes) 心内膜炎主要发生于免疫功能低下者,治疗采用安必西林和氨基糖苷类药物。

    • 诺卡氏菌属 (Nocardia spp.) 心内膜炎极为罕见,常与假体瓣膜相关,需要激进的抗生素治疗结合手术干预。

    • 红脓丝状杆菌 (Erysipelothrix rhusiopathiae) 心内膜炎与职业暴露和动物接触有关,通过阳性血培养诊断,治疗采用青霉素G。

    • 产气荚膜梭菌属 (Clostridium spp.) 心内膜炎表现为产气荚膜梭菌败血症症状,需要及时抗生素治疗,预后仍然较差。

    • 白喉棒状杆菌 (Corynebacterium diphtheriae) 心内膜炎通常与呼吸道或皮肤源相关,治疗采用青霉素和氨基糖苷类药物。

    • 不需营养链球菌属 (Abiotrophia spp.) 和 珍珠链球菌属 (Gemella spp.) 需要分子鉴定技术,治疗采用高剂量青霉素和氨基糖苷类药物。

      • 不需营养链球菌属 (Abiotrophia spp.) 约占所有链球菌性心内膜炎病例的5-6%。这些难培养的生物常被误诊为培养阴性IE,可能低估其流行率。90%的患者有既存心脏病,只有10%的病例涉及假体心脏瓣膜。临床表现通常缓慢且隐匿,随着疾病进展,可见败血性关节炎等并发症。通过增强培养基(包括胱氨酸补充)和分子技术如16S rRNA基因测序,诊断有所改善。治疗具有挑战性,抗生素治疗后细菌学失败率高达41%,需采用联合治疗如青霉素与庆大霉素或在某些情况下仅用万古霉素。发病率和死亡率超过其他链球菌型,部分患者需进行瓣膜置换或因无法控制的心力衰竭或栓塞事件而死亡。

      • 珍珠链球菌属 (Gemella spp.),包括Gemella morbillorum 和 Gemella haemolysans,在革兰染色过程中易脱色,常被误认为革兰阴性球菌。它们占被误分类为变异链球菌的显著比例。珍珠链球菌属引起的心内膜炎与口腔卫生差和先前的瓣膜损伤有关,表现为低度间歇性发热和两-thirds病例中的新发或改变的心脏杂音。常见栓塞表现,诊断依赖于准确的革兰染色解释和分子鉴定方法如16S rRNA基因测序。治疗通常采用青霉素和庆大霉素,报告结果良好,包括低死亡率和极少需要外科干预。

    HACEK组细菌:

    HACEK组包括难培养的小革兰阴性杆菌,主要来自口咽菌群,约占所有心内膜炎病例的3%。该组包括Haemophilus parainfluenzae、H. influenzae、H. aphrophilus、H. paraphrophilus、Actinobacillus actinomycetemcomitans、Cardiobacterium hominis、Eikenella corrodens和Kingella spp. 这些生物生长缓慢,在二氧化碳环境下生长更好,并需要特定的培养条件。每种HACEK菌呈现独特的流行病学和临床特征:

    • Haemophilus paraphrophilus:罕见,常与二尖瓣脱垂和先前瓣膜异常相关。临床表现包括发热、心脏杂音和栓塞事件。24%的病例需要瓣膜置换。

    • Haemophilus aphrophilus:通常与牙科手术和上呼吸道感染相关。超声心动图在70%的患者中检测到植被。诊断延迟的改善在最近报告中带来更好的预后。

    • Haemophilus parainfluenzae:隐匿性表现,常在牙科手术后出现。栓塞并发症频繁,病死率在10-35%之间。

    • Actinobacillus actinomycetemcomitans:与牙周疾病和先前牙齿感染相关。影响年轻至中年患者,病死率为9-15%,28%的病例需要瓣膜置换。

    • Cardiobacterium hominis:与牙科感染和基础心脏病相关,主要影响主动脉瓣。死亡率约13%,30%需要瓣膜置换。

    • Eikenella corrodens:常见于静脉吸毒者,由于注射器污染。通常病程轻微,病死率为15%,极少需要瓣膜置换。

    • Kingella spp.:Kingella kingae主要影响幼儿,而Kingella denitrificans较少见。老年患者中,假体瓣膜是显著的风险因素。Kingella属主要定植于上呼吸道,特别是扁桃体,并非主要病原体,而是利用病毒感染导致的黏膜损伤。儿童Kingella菌血症报告同时有口腔炎、咽炎或水痘病毒引起的口腔溃疡。在Kingella kingae心内膜炎中,病死率为16%,25%的病例检测到中枢神经系统栓塞。

    有效鉴定策略:

    有效的鉴定策略包括在严格条件下获取多份血培养——通常在24到48小时内获得三组血液样本,并确保足够的血量——以确立培养阳性的心内膜炎。由于HACEK细菌和其他难培养生物生长缓慢,必须延长培养时间(3至5天,某些如A. actinomycetemcomitans可延长至30天)。需要专门的培养方法,如在35至37°C,5-8%羊血和巧克力琼脂培养基上在5-10%的CO₂环境中亚培养。对于难以鉴定的菌,应使用16S rRNA基因分析等分子技术。许多患者接受过先前抗生素治疗,显著降低了血培养的阳性率。为减少这种情况,必须使用如将血样稀释在肉汤中、使用抗菌剂去除装置以及使用专门的培养基等方法来分离难培养生物。研究未发现Septicheck瓶和Isolator管在细菌生长上的显著差异。

    临床表现和诊断挑战:

    这些非典型病原体引起的IE可能表现为亚急性和隐匿的症状,常缺乏传统迹象如发热和心脏杂音,尤其在老年患者或已接受过抗生素治疗的患者中。其他临床表现包括:

    • 指端杵状指:在三分之一的患者中观察到,比其他形式的心内膜炎通常高。

    • 紫癜样皮疹:在五分之一的患者中发现,通常发生在四肢和黏膜上。皮肤活检显示免疫复合物性血管炎。

    • 肾脏受累:报告有增生性肾小球肾炎,增加肾功能不全的风险。实验室检查可能包括显微血尿、血清肝转氨酶升高、乳酸脱氢酶、肌酸激酶、冷沉淀物和高丙种球蛋白血症。

    • 栓塞表现:约20-41%的患者发生,包括脑和四肢血管。动脉栓塞可能表现为中风,可能需要栓子切除术或截肢。

    • 肺和胸膜表现:可能是心内膜炎的并发症。

    罕见IE类型的特定表现:

    • 惠普尔病心内膜炎:可能包括系统症状如腹泻、体重减轻、神经系统表现和急性充血性心力衰竭。

    • 军团菌心内膜炎:与慢性症状相关,如低度发热、夜汗、体重减轻和充血性心力衰竭症状,无栓塞事件。

    • Q热立克次体心内膜炎 (Coxiella burnetii Endocarditis):通常影响有既存瓣膜损伤的个体,表现为长期发热、心功能障碍、脾肿大和肝肿大。实验室发现通常包括高阶段IgG和IgA抗体、循环免疫复合物、类风湿因子、贫血、血小板减少、高丙种球蛋白血症和各种自身抗体。

    • 克雷伯菌心内膜炎:以先前的尿路感染为特征,高毒力涉及天然和假体瓣膜,如诊断延误,死亡率高达49%。超声心动图通常显示大型植被,血培养始终为阳性。心脏杂音可能缺失或被忽视,尤其是在右心性心内膜炎中。心肌脓肿可能导致培养阴性诊断,最终在手术后被识别。

    • 淋病奈瑟菌心内膜炎:影响较年轻的患者(平均年龄27岁),症状持续时间长(约45天),60%有发热,三分之一有急性充血性心力衰竭。与性传播疾病相关,常需瓣膜置换(50%的病例),尽管抗生素治疗,但死亡率高达25%。

    • 李斯特菌心内膜炎:主要发生在免疫功能低下者,表现为亚急性疾病,伴有发热、虚弱、呼吸困难和心脏杂音。常见急性充血性心力衰竭(50%),治疗包括安必西林和氨基糖苷类药物。

    • 乳酸杆菌心内膜炎:75%的病例与牙科操作相关,系统性栓塞发病率高(42%)。83%的患者有基础心脏病,39%未充分治疗的病例复发。

    • 诺卡氏菌属心内膜炎:极为罕见,主要在假体瓣膜患者中,尽管接受静脉抗生素治疗和瓣膜置换,死亡率仍高达67%。

    • 红脓丝状杆菌心内膜炎:与职业暴露相关(89%),尤其是屠夫和渔民,40%的患者有特征性皮肤病变(红疹样)。使用青霉素G治疗有效,尽管死亡率仍高(38%)。

    • 产气荚膜梭菌属心内膜炎:表现为产气荚膜梭菌败血症症状,如休克、黄疸和血管内溶血。尽管抗生素治疗,但死亡率高达47%,通常与静脉吸毒或基础恶性肿瘤相关。

    • 白喉棒状杆菌心内膜炎:常发生在咽炎或静脉吸毒的背景下,伴有心脏病如瓣膜损伤。治疗采用青霉素和氨基糖苷类药物。

    • 不需营养链球菌属心内膜炎:病程缓慢且隐匿,常见于有既存心脏病的患者(90%)。经典的外围表现如指端杵状指、出血点和奥斯勒结节不常见,但三分之一的患者发生栓塞。通过专门的培养基和分子技术诊断有所改善。治疗具有挑战性,细菌学失败率高,超过30%的菌株对青霉素有耐药性。联合疗法如青霉素与庆大霉素或仅用万古霉素在某些模型和患者群中显示出有效性。预后仍然较差,死亡率高,需要瓣膜置换。

    • 珍珠链球菌属心内膜炎:与口腔卫生差和先前瓣膜损伤相关,表现为低度间歇性发热和两-thirds病例中新发或改变的心脏杂音。常见栓塞事件,诊断依赖于准确的革兰染色解释和分子鉴定。治疗通常采用青霉素和庆大霉素,报告结果良好,包括低死亡率和极少的外科干预。

    治疗和预后:

    由罕见病原体引起的IE治疗通常涉及根据特定有机体的敏感性剖面定制的抗生素组合:

    • 巴通体心内膜炎:通常采用氨基糖苷类药物与多西环素或头孢曲松联合长期治疗。

    • 惠普尔病心内膜炎:需要针对T. whippelii的长期抗生素治疗,通常因瓣膜损伤严重需进行手术干预如瓣膜置换。

    • 军团菌心内膜炎:采用大环内酯类或氟喹诺酮类药物治疗。

    • Q热立克次体心内膜炎 (Coxiella burnetii Endocarditis):通常需要多西环素结合羟氯喹至少18个月,并进行血清抗体监测及羟氯喹血浆水平监测。

    • HACEK组细菌:采用稳定β-内酰胺酶的头孢菌素类药物治疗4周(天然瓣膜)或6周(假体瓣膜)。牙科手术的预防用药包括阿莫西林,过敏患者可用克林霉素或普利司达霉素。

    • 克雷伯菌心内膜炎:采用广谱头孢菌素或氟喹诺酮管理,尽管高死亡率需迅速诊断和积极治疗。

    • 奈瑟菌心内膜炎:需适当抗生素治疗并常需瓣膜置换,近年来预后有所改善。

    • 李斯特菌和乳酸杆菌心内膜炎:采用如安必西林和氨基糖苷类药物的组合治疗,未充分治疗的病例考虑高复发和死亡率。

    • 诺卡氏菌、红脓丝状杆菌、产气荚膜梭菌、白喉棒状杆菌、不需营养链球菌属和珍珠链球菌属心内膜炎:需要特定的抗生素方案,常结合手术干预以改善预后。死亡率各异,某些感染如*Clostridium spp.*尽管治疗但预后特别差。

    • 珍珠链球菌属特别对青霉素和庆大霉素反应良好,报告的结果良好,包括低死亡率和极少外科干预。

    IE由罕见病原体引起的预后可能较差,尤其在诊断和治疗延误的情况下。感染如克雷伯菌和产气荚膜梭菌心内膜炎死亡率高。然而,诊断和治疗策略的进步,包括使用分子技术和定制抗生素疗法,已改善许多患者的预后。早期识别和适当管理对降低死亡率和手术需求至关重要。

    其他罕见病因:

    除详细列出的病原体外,IE的其他罕见致病因素包括:

    • 分枝杆菌属 (Mycobacterium spp.):耐酸醇的细菌,导致极为罕见的心内膜炎形式,常与假体瓣膜或医疗程序相关。诊断依赖于组织学检查和专门的培养技术,推荐组合抗生素治疗。

    • 支原体属 (Mycoplasma spp.):无细胞壁的细菌,极少报告IE病例。由于无法通过革兰染色观察和在常规培养中生长,检测具有挑战性。分离策略包括特定的琼脂培养基和PCR技术。

    • 巴斯德杆菌属 (Pasteurella spp.):小型、革兰阴性、非鞭毛的球杆菌,常与与猫或狗密切接触相关(44%的病例)。由巴斯德杆菌属引起的心内膜炎报告了21例,死亡率为31%,通常与诊断延误相关,而非抗生素耐药。

    • 布鲁氏菌属 (Brucella spp.):小型兼性厌氧、革兰阴性、胞内细菌,主要通过摄入受污染的牛奶或与感染动物密切接触引起人畜共患感染。布鲁氏菌心内膜炎发生在布鲁氏菌病病例的0.3-0.6%,死亡率高。诊断依赖于长期的血培养孵育和血清学测试,而治疗通常包括多西环素和利福平或链霉素的组合数月,并常伴有手术干预。

    • 伯氏杆菌属 (Bordetella spp.):仅报道了一例Bordetella holmesii心内膜炎,通过分子技术在一名患有二尖主动脉瓣的患者的血培养中分离后诊断。

    • 军团弧菌属 (Francisella tularensis):仅报导了一例心内膜炎,通过使用放射性系统的长期血培养孵育鉴定。

    • 水气单胞菌 (Aeromonas hydrophila):在肝硬化患者中报告了两例心内膜炎,与水源暴露相关。

    • 耶尔森菌属 (Yersinia enterocolitica):报告了十二例心内膜炎,通常发生在有基础疾病如铁负荷过重或免疫抑制的患者中。治疗通常包括广谱头孢菌素和庆大霉素,未经治疗的病例死亡率为25%。

    • 沙门菌属 (Salmonella spp.):报告了三十三例心内膜炎,主要是Salmonella enterica Enteritidis血清型。主要发生在同时或之后伴有沙门菌感染如肠胃炎,尤其在免疫功能低下或有假体瓣膜的个体中。超声心动图通常显示大型植被,血培养阳性。

    结论:

    增强的超声心动图方法与Duke标准相结合,结合先进的微生物学和分子诊断,可显著提高由较少见和难培养的细菌引起的感染性心内膜炎的检测和管理。了解这些罕见病原体的流行病学、临床表现,以及适当的诊断和治疗策略对改善患者预后至关重要。特别是在培养阴性病例中,积极探查非典型生物,并基于患者病史和临床特征保持高度怀疑,对及时准确的诊断和有效治疗至关重要。

    致谢

    我们感谢J. S. Dumler(美国马里兰州巴尔的摩的约翰霍普金斯医学院)审阅英语使用。